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Abstract
Background: The angiotensin-converting enzyme (ACE) I/D polymorphism has been reported to be associated with Kawasaki 
disease(KD) ,but  studies to date present conflicting results.
Objectives: The aim of  this study is to derive a more precise estimation of  the association between the ACE I/D polymorphism 
and KD risk.
Methods: PubMed,EMBASE,CNKI and Wangfang databases were retrievaled to identify for relevant studies from  inception to 
May 2017.Pooled odds ratios (OR) with 95% confidence intervals (CI) were  calculated using Stata 12.0 software.
Results: A total of  6 case-control studies comprising 634 patients and 458 controls were included in the meta-analysis,and  we 
found a significant association between the ACE I/D polymorphism and KD risk(D vs I:OR = 0.81, 95%CI = 0.31-2.11;DD vs 
II: OR = 1.03, 95%CI = 0.42-2.54; DI vs II: OR = 1.44, 95%CI = 1.09-1.90; dominant model: OR = 1.43, 95%CI = 1.11-1.85; 
recessive model: OR = 1.21, 95%CI = 0.44-3.29 ).When stratified by sample size>200,  this polymorphism is associated with an 
increased the risk of  KD.
Conclusion: The I/D polymorphism in the ACE gene may be associated with susceptibility to KD.
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Kawasaki disease(KD) is an self-limited vasculitis that 
mainly affects young children1. Although KD was first 
described in 19672, its etiology is still not fully under-
stood.The clinical manifestations of  KD include per-
sistent fever, non-purulent conjunctivitis, diffuse muco-
sal inflammation, polymorphous skin rashes, indurative 
angioedema of  the hands and feet, and non-suppurative 
cervical lymphadenopathy3. In about 20% of  patients 
vasculitis will lead to coronary artery lesions as detect-
ed by echocardiography, showing this to be the principal 
cause of  acquired heart disease of  children4. Recent stud-
ies suggest that gene polymorphisms maybe  associated 
with KD, such as the FCGR2A gene rs1801274 polymor-
phism5.
The renin-angiotensin system (RAS) has been implicat-
ed in modulating blood pressure and homeostasis of  the 
cardiovascular system6. Angiotensin-converting enzyme 
(ACE) is an crucial circulating enzyme of  the RAS.It 
catalyzes the conversion of  angiotensin I to angiotensin 
II and mediates bradykinin degradation7. In addition,-
angiotensin II is a potent pro-inflammatory modulator 
that augments and perpetuates immune responses. The 
human ACE gene is located on chromosome 17q23 and 
a large number of  polymorphisms have been identified.
African Health Sciences Vol 17 Issue 4, December, 2017991
@ 2017 Pan et al; licensee African Health Sciences. This is an Open Access article distributed under the termsof  the Creative commons Attribution 
License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.  
African 
Health Sciences
One intron 16 insertion/deletion (I/D,rs4646994) poly-
morphism of  this gene is characterized by the presence 
or absence of  a 287bp Alu repetitive sequence9. Homozy-
gotes for the D allele have the highest plasma ACE levels, 
heterozygotes(ID) have intermediate levels, and homozy-
gotes for the I allele have the lowest levels10.  
Many studies have investigated the relationship between 
ACE I/D polymorphism and KD. The inconsistency of  
these results may have resulted from inadequate statistical 
power owing to small sample size and eco-geographical 
differences.Meta-analysis may overcome these limitations 
of  individual research11. We performed this meta-analysis 
to arrive at a more accurate estimation of  the association 




Computer searches of  PubMed,EMBASE,CNKI and 
Wangfang databases were performed via the following 
key words:“ACE gene”,“Kawasaki disease/KD”, “I/D”, 
“single nucleotide polymorphism” and “genetic polymor-
phism”. Only human studies were selected. Additional ar-
ticles were identified by a manual searching of  the refer-
ences of  in the related original studies.
Study selection
Articles included in the meta-analysis met the following 
inclusion criteria:1) relevant case-control studies of  KD 
cases and healthy controls; 2) articles on the relation of  
the ACE I/D polymorphism and susceptibility to KD 
and 3) studies that included sufficient genotype informa-
tion for extraction.Exclusion criteria were as follows: 1) 
not case-control studies; 2) case reports, reviews, or me-
ta-analysis; 3) studies that were based on incomplete raw 
data.
Data extraction
The collected data included the first author’s surname, 
publication date, country of  origin, ethnicity,the number 
of  cases and controls, the genotype frequency of  ACE 
I/D polymorphism and deviation from Hardy-Weinberg 
Equilibrium (HWE) of  the control group.
Statistical analysis
Fisher’s exact test was used to test HWE for distributions 
of  genotypes among controls.The strength of  the correla-
tion between ACE I/D polymorphism and susceptibility 
to KD was estimated by odds ratio (OR) and 95% confi-
dence interval (95%CI) as follows:D vs I, a homozygote 
comparison (DD vs II), a heterozygote comparison (DI 
vs II), a dominant model (DD+DI vs II) and a recessive 
model (II+DI vs DD) between groups.The heterogeneity 
among these articles was checked via the I2 test.When I2 
> 50% indicated heterogeneity across studies,the random 
effects model was used,otherwise the fixed effects model 
was performed. The sensitivity analysis was performed by 
used via omitting each individual article, and an individual 
article was suspected of  excessive sensitivity if  the point 
estimate of  its omitted analysis was outside the 95% CI 
of  the pooled analysis.To assess the potential publication 
bias, Begg’s and Egger’s tests were performed.All statisti-
cal tests were performed with STATA (version 12.0; Stata 
Corporation, College Station, TX).
 
Results            
Study characteristics
The database search yielded 137 publications, of  which 
both of  the reviewers considered 10 to be potentially 
eligible.We excluded 4 of  the articles during the second 
phase of  the inclusion process.The remaining 6 articles 
were included in the combined analysis12-17. A The flow 
chart summarizing the study selection process is shown 
in Figure 1. Included studies were all performed in Chi-
na,Japan or Korea. All studies were in agreement with 
HWE except Shim et al,Wan et al and Xie et al15-17.The 
principle characteristics of  eligible studies are summa-
rized in Table 1.
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Year Area Race Cases/ 
Controls 
Allele  for 
cases 








          D      I D      I DD   ID    II DD   ID    II       
Wu 2004 China Asian 107/107 83  131 88   126 6     71   30 18    52    37 0.97 
Fuzakawa 2004 Japan Asian 276/145  19   362 94   196 33    126  117 12    67    66 0.38 
Liu 2005 China Asian 28/35  44   12  36   34 18    6    4 9     19    7    0.60 
Shim 2006 Korea Asian 55/43 47   63 49   37 7     33   15 18    13    12 0.01 
Wan 2006 China Asian 138/98 167   109  78   118 60    47   31 24    30    44 0.00 




A summary of  the meta-analysis findings of  the associ-
ation between ACE I/D polymorphism and KD risk is 
shown in Table 2 and Figure 2. Pooled analysis suggests 
that the ACE I/D polymorphism was significantly associ-
ated with KD(D vs I:OR = 0.81, 95%CI = 0.31-2.11;DD 
vs II: OR = 1.03, 95%CI = 0.42-2.54; DI vs II: OR = 
1.44, 95%CI = 1.09-1.90; dominant model: OR = 1.43, 
95%CI = 1.11-1.85; recessive model: OR = 1.21, 95%CI 
= 0.44-3.29 ).In sub-group analysis by sample size,the 
studies were divided into sample size>200 and sample 
size≤200,and significant association was found between 
the ACE I/D polymorphism and KD risk in sample 
size>200(D vs I:OR = 0.62, 95%CI = 0.12-3.11;DD vs 
II: OR = 1.40, 95%CI = 0.46-4.28; DI vs II: OR = 1.41, 
95%CI = 1.04-1.91; dominant model: OR = 1.60, 95%CI 
= 0.93-2.74; recessive model: OR = 0.92, 95%CI = 0.31-
2.74).However, when the analyses were restricted to small 
studies (n≤200 subjects), meta-analysis results showed no 
significant association.Moreover, when limiting the anal-
ysis to the study deviating from HWE, a significantly in-
creased risk was observed(D vs I:OR = 0.98, 95%CI = 
0.36-2.69;DD vs II: OR = 0.80, 95%CI = 0.13-4.84; DI 
vs II: OR = 2.18, 95%CI = 1.32-3.58; dominant model: 
OR = 1.66, 95%CI = 0.82-3.39; recessive model: OR = 
1.98, 95%CI = 0.32-12.36).
Table 2. Summary of different comparative results. 
 
  N     OR(95%CI)     
Variables    D vs I DD vs II DI vs II Dominant model Recessive mode 
Total 6 0.81(0.31-2.11) 1.03(0.42-2.54) 1.44(1.09-1.90) 1.43(1.11-1.85) 1.21(0.44-3.29) 
Sample 
size 
            
＞200 3 0.62(0.12-3.11) 1.40(0.46-4.28) 1.41(1.04-1.91) 1.60(0.93-2.74) 0.92(0.31-2.74) 
≤200 3 0.95(0.65-.38) 0.72(0.16-3.17) 1.60(0.80-3.18) 1.17(0.63-2.16) 1.59(0.19-13.43) 
HWE             
Yes 3 0.69(0.12-4.04) 1.22(0.41-3.66) 1.19(0.85-1.67) 1.22(0.88-1.68) 0.77(0.18-3.30) 
No 3 0.98(0.36-2.69) 0.80(0.13-4.84) 2.18(1.32-3.58) 1.66(0.82-3.39) 1.98(0.32-12.36) 
 
N: number; CI: confidence interval; OR: odds ratio 
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To evaluate the effect of  a single article on the final result, 
we used a sensitivity analysis via removing one study at a 
time. Ultimately the pooled results hardly changed after 
removal of  each study, suggesting that our results were 
robust (Figure 3).
 
Figure 3. One-way sensitivity analysis of the pooled odds ratios and  
95% confidence interval. 
 
Figure 2 .Forest plots for the association of ACE I/D polymorphism with risk of KD. 
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Publication bias
Begg’s and Egger’s tests were used to assess the publi-
cation bias for ACE I/D polymorphism.The shape of  
the funnel plot did not reveal any evidence of  obvious 
asymmetry, suggesting no evidence of  publication bias 
for ACE I/D polymorphism(Figure 4 and Figure 5).
 
 
Figure 4. Begg’s funnel plot test of publication bias. 
 
 
Figure 5. Egger’s funnel plot test of publication bias. 
 
 
Figure 4. Begg’s funnel plot test of publication bias. 
 
 
Figure 5. Egger’s funnel plot test of publication bias. 
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Discussion
Although the morbidity is highest in Asians, KD is a major 
cause of  acquired heart disease throughout the world18. 
After much investigation,the pathogenesis of  KD is still 
not yet well understood.ACE not only increases vascular 
smooth muscle cell contraction, but also affects smooth 
muscle proliferation, monocyte adhesion, platelet adhe-
sion, and aggregation19,20. To date,many studies have at-
tempted to analyze the association between ACE I/D 
polymorphism and KD susceptibility, but the results have 
been are inconsistent. The aim of  this meta-analysis was 
to investigate the possible association between ACE I/D 
polymorphism and KD risk based on relevant studies.
In this meta-analysis, we addressed the association be-
tween ACE I/D polymorphism and susceptibility to KD. 
Our results indicated that the ACE I/D polymorphism 
was significantly associated with the risk of  KD. Nev-
ertheless, considering that other potential factors might 
influence the final result, we conducted sub-group anal-
ysis.In a stratified analysis by sample size,pooled results 
showed significant association with sample size>200 but 
not with sample size≤200, suggesting that there was no 
small-study bias in this meta-analysis. The results of  our 
study differ from a previous meta-analysis21. Our me-
ta-analysis included six studies, and three recent studies 
by Liu et al,Wan et al and Xie et al were included in the 
present analysis.The previous meta-analysis performed 
by Lee et al suggested that the ACE I/D polymorphism 
is associated with several kinds of  vasculitis(Behçet’s 
disease and Henoch-Schonlein purpura),but not with 
KD.The author of  the previous meta-analysis did not 
speculate as to the reasons for the disparate results. The 
difference may be due to small sample sizes.  
Several limitations should be acknowledged of  the cur-
rent study. First, in the pooled analysis, we found that 
the ACE I/D polymorphism was significantly associated 
with the risk of  KD in studies with PHWE<0.05. The 
data indicated that selection bias or genotyping error may 
have affected the merged results. Second, only the ACE 
I/D polymorphism was analyzed in this meta-analysis. 
Further analysis should clarify the association of  oth-
er polymorphisms in the RAS genes, such as the AGT 
M235T and T174M polymorphisms. Third, we  were un-
able to include unpublished studies, which might affect 
the publication bias. Additionally, there is a lack of  infor-
mation for the other population outside Asia. Therefore, 
the results of  the current study are not comprehensive.
Conclusion
Our pooled data showed a significant association be-
tween the ACE I/D polymorphism and the risk of  KD. 
Due to the defect limitations of  the included research, 
future large-scale investigations with appropriate design 
are required to confirm association.
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